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This issue begins with a Letter to the Editor concerning an article published last year on photodynamic and sonodynamic therapy, together with a response from the authors of the original article. We encourage Letters to the Editor about journal articles, which are always interesting for our readers.
We are also pleased to have a commentary, submitted by Ira Cantor of Steiner Medical and Therapeutic Center in Pennsylvania. Cantor discusses issues on colon cancer screening, and whether current recommendations might be modified by taking into account patients' lifestyles as a move towards a more efficient health care system. Potential cost effectiveness of integrative approaches is a subject of great interest to this journal, and we are pleased to see this suggestion.
Jong-Kin Kim and associates at Kyung Hee University in Korea review the use of reflexology for breast cancer symptoms. Reflexology is a therapeutic system based on the manipulation of reflexes thought to be on the feet and hands that refer to and can be used to affect other organ systems in the body. The literature on the effect of this approach is still sparse, and these authors identify areas of concern of which investigators should be aware in future studies.
Bojungikki-tang is an herbal prescription widely used in the traditional medical practices of China, Korea and Japan. We are pleased to have a pilot clinical trial of this formula contributed by Jong-Soo Jeong also of Kyung Hee University, in the current issue. This study is a randomized trial involving 40 patients with cancer-related fatigue, using a waiting-list control group. The positive impact on fatigue observed in this trial indicates promise for larger investigations.
Jun Mao and colleagues at the University of Pennsylvania are the authors of an article on positive changes experienced during the cancer experience. Accounts of patients experiencing positive spiritual growth through the cancer experience are not uncommon. Surveying a large population identified through a cancer registry, they found that roughly equal numbers of patients experienced highly positive and negative spiritual changes. What is particularly interesting about this paper is that they found that those who experienced positive changes were about twice as likely to use CAM therapies as those who did not experience such changes. Whether this CAM use encouraged the positive outcome or was a result of persons experiencing positive changes, of course, can't be determined from this correlational design, but it is a most interesting finding.
Lorenzo Cohen and colleagues from M.D. Anderson Cancer Center and Fudan University Cancer Hospital in China present a small study on external qigong therapy for women with breast cancer. In external qigong therapy, a qigong master projects his own qi energy into patients to improve their health in various ways. This is different from the use of internal qigong, in which patients participate in physical qigong exercises. Based on reports of patients seeking external qigong therapy to treat cancers, and on reports of in vitro studies of energy therapy on tumors, an M.D. Anderson team provided an opportunity for a Chinese qigong master to treat patients with small breast tumors prior to surgery, in a pilot study design. When no response was found to the treatments, the study was then moved to China so that the study could take advantage of the cultural environment in which qigong evolved. We are pleased to see specific evidence brought to bear on the question of disease responses to energy therapies, which is definitely a matter of concern to patients. We also salute the flexibility the investigators showed in being ready to change the country in which treatments were given to allow the qigong therapy to be evaluated in a more culturally relevant context.
Yibin Feng and Saiwah Tsao of the University of Hong Kong explored the ability of the traditional Chinese medicine herb Coptidis rhizoma, or Coptis chinensis, to inhibit movement of hepatoma cells, a critical step in development of metastatic disease. Coptidis rhizoma is well known as a source of berberine, and this phytochemical indeed proved to be critical in the inhibitory action observed. Berberine is also known to have anti-inflammatory activities. This paper adds an interesting dimension to the use of this potent phytochemical.
Ultrasound is being studied as a means to treat cancer, and several papers have been published in this area in Integrative Cancer Therapies in the past. Ultrasound is usually applied along with one of several sonosensitizers, which tend to be natural products. The paper by Zedan Tian and colleagues in this issue uses the compound hematoporphyrin, a derivative of hemoglobin. Interestingly, this compound also has a strong photosensitizing effect and has been explored as 1 Block Center for Integrative Cancer Treatment, IL Integrative Cancer Therapies 9(4) a component of photodynamic therapy as well as of ultrasound therapy.
Ultrasound is, one could say, a type of energy therapy in that it can deliver focused energy inside a tissue. Another sort of energy is heat, and our next paper concerns hyperthermia, along with the use of a natural product, Withania somnifera, sometimes called Indian ginseng. Guruprasad Kalthur and Uma Devi Pathirissery applied hyperthermia and Withania treatment alongside radiation therapy. Hyperthermia is known to enhance responses to radiation and chemotherapy, and these authors combined radiation with these two radiosensitizers to see ultimately if they might facilitate lower therapeutic doses of radiation.
Our final paper in this issue, by Shaival Rao and Priya Rao of the C.U. Shah College of Pharmacy and Research, examines another radiosensitizing herb, Tinospora cordifolia. This herbal extract was found to decrease viability of cancer cells treated with varying doses of radiation. A decrease in glutathione-S-transferase was found, along with an increase in lipid peroxidation. This is a significant initial study, but of course later, follow-up research will have to determine whether the herb also increases the radiosensitivity of normal cells.
Announcement of start of online publication of Letters to the Editor, commentaries, case studies and in vitro studies
The rate of submissions to Integrative Cancer Therapies has grown in a very gratifying way in the last year. We are particularly pleased to see the wide international representation of well-done papers. However, the inevitable consequence of receiving many manuscripts deserving of publication is that we run up against page limitations in the paper journal publication. With the economic downturn, it is not an easy matter to simply increase the number of issues of the journal to accommodate this larger number of interesting manuscripts, which would certainly be a preferred strategy. Fortunately, our publisher, Sage Publications, will facilitate a different way to resolve this problem by introducing an on-line only component to the journal. Starting with manuscripts submitted October 1, 2010, Letters to the Editor, commentaries, case studies and in vitro studies with no in vivo component to them will be published in an online-only supplement to the journal, although articles in these categories of special interest could be published in the paper version as well. Our choice of the in vitro-only papers for online-only publication has been made because the bulk of our subscribers are working in clinical settings, and while the in-vitro papers are of great interest and relevance, we hope to move the journal towards a type of publication with a more clinical emphasis in the future. Each manuscript published online-only will be assigned to a specific issue of the paper journal, and will appear in the Table of Contents of that issue, with digital object identifiers to facilitate their retrieval. They will, of course, be indexed with the rest of the papers in PubMed and other indexing services. The journal is already available in an online-only subscription form, and many institutional libraries receive it in this electronic format. This move will simply enlarge that online-only component of the journal, allowing better access to quality in-vitro articles.
